Skip to content

Leukotriene E4/Creatinine Ratio, Urine

Published: August 9, 2026Updated: August 16, 2026

Measures urinary leukotriene E4 relative to creatinine, providing a way to account for urine concentration when evaluating leukotriene release.

Quick summary

["This urine test measures leukotriene E4 activity and may help evaluate suspected mast-cell mediator release when used with other findings."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
33343-5
Short code
LTE4/Creat Ur
Synonyms
LTE4/Creat Ur
Category
kidney
Sample
urine
Container
Sterile urine container
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Specimen volume
10 mL
Stability
Room temperature: 2h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
0
Lipemia max
0
Icterus max
0
TAT
4–24 hours
Order
routine

What is this test?

Leukotriene E4, or LTE4, is a breakdown product of leukotrienes, which are signaling molecules involved in inflammation. This test measures LTE4 in urine and compares it with urinary creatinine, a substance used to account for differences in urine concentration.

Why might I need this test?

A clinician may order this test as an adjunct when evaluating symptoms that could be related to mast-cell activation, such as recurrent flushing, hives, abdominal symptoms, wheezing, or unexplained anaphylaxis. The result is generally interpreted with the medical history, examination, and other laboratory tests because symptoms and urine LTE4 levels can have many causes.

How is the test performed?

A urine sample is collected and tested to determine the amount of LTE4 and creatinine. The laboratory then calculates the LTE4-to-creatinine ratio, which can help reduce the effect of variations in urine concentration.

How do I prepare for the test?

Follow the collection instructions provided by the clinic or laboratory, including whether a single urine specimen or a timed collection is required. Tell your clinician about all medicines, supplements, and recent changes in diet, because some can affect inflammatory markers or urine testing.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

An elevated urine LTE4-to-creatinine ratio may indicate increased leukotriene production, which can occur with mast-cell activation and related inflammatory conditions. A low result or a result that fluctuates does not rule out a mast-cell disorder. Interpretation depends on the collection method, clinical symptoms, medications, diet, and other test results.

Short name

Urine LTE4/Creatinine Ratio

Frequently asked questions

Does this test diagnose mast-cell disease?
No. It is an adjunctive test that measures leukotriene activity, and abnormal results must be interpreted with symptoms, examination findings, and other laboratory results.
Why is creatinine included in the result?
Creatinine helps account for how concentrated the urine is. Dividing or comparing LTE4 with creatinine makes the measurement more comparable between samples.
Can medicines or diet affect the result?
Yes. Certain medicines, supplements, and foods may affect leukotriene production or laboratory measurements, so it is important to tell the ordering clinician about them before testing.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy